
1. Nat Commun. 2018 May 2;9(1):1769. doi: 10.1038/s41467-018-04104-z.

Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among
Cambodian Plasmodium falciparum.

Bopp S(1), Magistrado P(1), Wong W(1), Schaffner SF(1)(2), Mukherjee A(1), Lim
P(3), Dhorda M(4)(5)(6), Amaratunga C(3), Woodrow CJ(5), Ashley EA(6)(7), White
NJ(5)(7), Dondorp AM(5)(7), Fairhurst RM(3), Ariey F(8), Menard D(9)(10)(11),
Wirth DF(1)(2), Volkman SK(12)(13)(14).

Author information: 
(1)Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
(2)The Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
(3)National Institutes of Health, Rockville, MD, 20892, USA.
(4)Worldwide Antimalarial Resistance Network, Bangkok, 10400, Thailand.
(5)Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, 10400, Thailand.
(6)Myanmar-Oxford Clinical Research Unit, Yangon, Myanmar.
(7)Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, 
OX3 7FZ, UK.
(8)Institut Cochin, INSERM U:1016, Parasitology-Mycology Unit, Cochin Hospital
Paris Descartes University, Paris, 75014, France.
(9)Biology of Host-Parasite Interactions Unit, Institut Pasteur, Paris, 75015,
France.
(10)CNRS, ERL 9195, Paris, 75794, France.
(11)INSERM, Unit U1201, Paris, 75015, France.
(12)Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
svolkman@hsph.harvard.edu.
(13)The Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
svolkman@hsph.harvard.edu.
(14)Simmons College, Boston, MA, 02115, USA. svolkman@hsph.harvard.edu.

Multidrug resistant Plasmodium falciparum in Southeast Asia endangers regional
malaria elimination and threatens to spread to other malaria endemic areas.
Understanding mechanisms of piperaquine (PPQ) resistance is crucial for tracking 
its emergence and spread, and to develop effective strategies for overcoming it. 
Here we analyze a mechanism of PPQ resistance in Cambodian parasites. Isolates
exhibit a bimodal dose-response curve when exposed to PPQ, with the area under
the curve quantifying their survival in vitro. Increased copy number for
plasmepsin II and plasmepsin III appears to explain enhanced survival when
exposed to PPQ in most, but not all cases. A panel of isogenic subclones
reinforces the importance of plasmepsin II-III copy number to enhanced PPQ
survival. We conjecture that factors producing increased parasite survival under 
PPQ exposure in vitro may drive clinical PPQ failures in the field.

DOI: 10.1038/s41467-018-04104-z 
PMCID: PMC5931971
PMID: 29720620  [Indexed for MEDLINE]

